Navigation Links
Mentice AB Announces Leadership Changes Within Its Worldwide Operations

GOTHENBURG, Sweden, March 11 /PRNewswire/ -- Mentice AB, a leading supplier of virtual reality based training applications within the field of medicine has recently appointed James Ruscoe as Chairman of the Board and Goran Malmberg as President and CEO of Mentice.

Mr. Ruscoe graduated from Oxford University and brings with him a vast array of experience in innovative technologies. He also serves as CEO and board member of several Swiss private and charitable foundations. Mr. Ruscoe is the former advisor to the Presidency of the European Commission on the competitive implications of innovation; to the Chairman of the European Round Table of Industrialists, Brussels; and to the Chairman of the Italian National Agency for Innovation, New Technologies and the Environment, Rome.

Mr. Malmberg, formerly a member of the Mentice board, has extensive sales and marketing experience from executive positions within the software industry and has held sales management and senior executive roles with international focus during the last 15 years.

"I am excited about joining Mentice which I personally feel is an innovative and progressive company in a market with considerable potential. My goal is to develop the company through further product development while enhancing our sales and marketing operations. We trust the industry will notice the result of these changes in the very near future as Mentice works to maintain its leadership position by broadening its presence throughout the worldwide VR marketplace," said Goran Malmberg.

About Mentice:

Mentice is a leader in medical simulation with approximately 600 installations worldwide, 100 validation studies and more than 30 issued and pending patents. Mentice's Family of Procedicus (TM) simulators focus on the area of minimally invasive surgery within the fields of endovascular, cardiovascular and neurological intervention, core skills training, laparoscopy and arthroscopy.

Website info:

Release #31008

SOURCE Mentice Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
2. Anesiva Announces Submission of Supplemental New Drug Application for Zingo(TM) to Reduce Pain Associated With Needle Insertion Procedures in Adults
3. Lilly Announces Termination of AIR Insulin Program
4. Oncothyreon announces March 10th webcast of fourth quarter and full year financial results conference call
5. Spectral announces 2007 financial results
6. Finesse Solutions, LLC Announces OPC Connectivity With Nova BioProfile 400
7. Jazz Pharmaceuticals, Inc. Announces Webcast of March 13 Investor Meeting
8. Senetek PLC Announces Appointments of Key Personnel
9. Iomai Announces Year-End 2007 Financial Results and Business Progress
10. Dragon announces new product launch; increase in annual production output capacity
11. Edwards Lifesciences Announces First Human Implants of Next-Generation Transcatheter Heart Valve
Post Your Comments:
(Date:11/24/2015)... Malaysia , Nov. 24, 2015  Asia-Pacific ... contract research organisation (CRO) market. The trend of ... in lower margins but higher volume share for ... capacity and scale, however, margins in the CRO ... Organisation (CRO) Market ( ), finds ...
(Date:11/24/2015)... ... November 24, 2015 , ... Copper is an essential ... bound to proteins, copper is also toxic to cells. With a $1.3 million ... (WPI) will conduct a systematic study of copper in the bacteria Pseudomonas aeruginosa ...
(Date:11/24/2015)... PHILADELPIA, PA (PRWEB) , ... November 24, 2015 , ... ... young entrepreneurs at competitive events in five states to develop and pitch their BIG ... student projects from each state are competing for votes to win the title of ...
(Date:11/24/2015)... QUEBEC CITY , Nov. 24, 2015 /PRNewswire/ ... (the "Company") announced today that the remaining 11,000 ... Common Share Purchase Warrants (the "Series B Warrants") ... agreement were exercised on November 23, 2015, which ... Common Shares.  After giving effect to the issuance ...
Breaking Biology Technology:
(Date:11/17/2015)... Paris from 17 th until 19 th ... from 17 th until 19 th November 2015.   ... the first combined scanner in the world which scans both ... two different scanners were required: one for passports and one ... same surface. This innovation is an ideal solution for electronic ...
(Date:11/12/2015)... Nov. 12, 2015  A golden retriever that stayed ... dystrophy (DMD) has provided a new lead for treating ... the Broad Institute of MIT and Harvard and the ... . Cell, pinpoints a protective ... the disease,s effects. The Boston Children,s lab of ...
(Date:11/10/2015)... 2015 About signature verification ... to identify and verify the identity of an ... the secure and accurate method of authentication and ... individual because each individual,s signature is highly unique. ... dynamic signature of an individual is compared and ...
Breaking Biology News(10 mins):